News & Views
Can we trust Pfizer to help keep us alive? Pfizer buys Sickle Cell drug maker Global Blood for $5.4B
BY MICHAEL THOMAS Pfizer has made a mega purchase recently acquiring Sickle Cell drug maker Global Blood Therapeutics, Inc. for...
Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!